You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 15, October 19, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Medical News & Perspectives
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Facial Plastic Surgery
 •Biomaterials and Implants
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Researchers Size Up Nanotechnology Risks

Tracy Hampton, PhD

JAMA. 2005;294:1881-1883.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Nanotechnology, a burgeoning field featuring tiny materials, may be poised to transform medicine with potential uses spanning all aspects of disease diagnosis, prevention, and treatment. In oncology alone, researchers envision using nanomaterials (which by definition have at least one dimension ranging from 1 nm [one billionth of a meter] to 100 times that) to detect early cancers, pinpoint tumors within the body, deliver toxic drugs specifically to malignant cells, and determine a therapy’s effectiveness. Similar medical uses may exist for arthritis, heart disease, and many other conditions.


More research is needed to assess the safety of nanomaterials, novel materials that have at least one dimension that does not exceed 100 nanometers in size. (Image reproduced with permission from Science. 2004;303:348-352.) (Photo credit: AAAS)

But even if these advances are achievable, little is known about the safety of nanomaterials in medicine or in other applications, such as . . . [Full Text of this Article]

LACK OF DATA



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.